In 2023, digital health funding halved for the second year in a row to hit $13.2B, down 75% from its peak in 2021.
However, investors still see opportunities for digital health innovation and are backing plenty of early-stage deals. While mid- and late-stage digital health deal sizes have dropped considerably since 2021, the median early-stage deal size in digital health actually increased by 19%.
Early-stage digital health startups are drawing funding to tackle problems both old and new, from long-standing barriers to accessible and equitable women’s healthcare to post-pandemic employee demands for more support and care.
To see where digital health tech is going in 2024, we looked for the tech markets with the most early-stage activity in 2023:
- Tele-psychiatry providers
- Virtual & hybrid women’s healthcare
- Virtual primary & specialty care
- Chronic disease & lifestyle management
- Corporate wellness platforms
- Maternal & fetal health screening
We dig into the trends shaping each market below.
